Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The Lancet , 368(9548), 1696-1705
At the end of 2022, Sosei Heptares had announced that its long-term collaboration with Pfizer had advanced the first candidate drug, Lotiglipron (PF-07081532), to Phase 2 clinical trials
While it may feel tough to eat when you face these symptoms, certain foods can actually nourish you and help manage them: For nausea: To reduce nausea, its best to eat smaller and more frequent meals
A mitochondrial DNA variant elevates the risk of gallstone disease by altering mitochondrial function
US$ 22.65
US$ 26.75
US$ 27.23
US$ 25.66
